Recent developments in olfactory neuroblastoma research
Anthony Ghanem1, John B Finlay1,2, David W Jang1
1Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine.
Purpose Of Review:
Olfactory neuroblastoma (ONB) is a rare malignancy originating from olfactory neuroepithelial cells. Given its uncommon nature and complex clinical presentation, this comprehensive review highlights recent findings and treatment approaches for advancing clinical practice and research.
Recent Findings:
Recent literature emphasizes significant advancements in the genomic profiling and molecular classification of ONB. Emerging targeted therapies include somatostatin analogs and programmed death-ligand 1 (PD-L1) inhibitors. In addition, the development of genetically engineered mouse models has provided valuable platforms for testing new treatment strategies, revealing similarities between ONB and small cell lung cancer, which may inform future therapeutic approaches.
Summary:
These findings have profound implications on clinical practice. Improved diagnostic accuracy through advanced imaging and genomic profiling in addition to identifying specific mutations for targeted therapy can lead to personalized treatments of patients with ONB. Developments in genetically engineered mouse models and multiinstitutional collaborative efforts are vital for advancing research and standardizing molecular testing. The integration of advanced imaging techniques, genomic profiling, and targeted therapies holds promise for improving patient outcomes and understanding this rare malignancy.
Insights
Olfactory neuroblastoma (ONB) research shows advances in genomic profiling and targeted therapies like PD-L1 inhibitors. New mouse models aid treatment strategies for this rare cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Olfactory neuroblastoma (ONB) is a rare malignancy of olfactory neuroepithelial cells.
- Its uncommon nature and complex presentation pose diagnostic and therapeutic challenges.
Purpose of the Study:
- To review recent findings and treatment approaches for olfactory neuroblastoma.
- To highlight advancements for improving clinical practice and research in ONB.
Main Methods:
- Comprehensive literature review of recent advancements in ONB.
- Analysis of genomic profiling, molecular classification, and targeted therapies.
- Evaluation of genetically engineered mouse models for ONB research.
Main Results:
- Significant progress in genomic profiling and molecular classification of ONB.
- Emerging targeted therapies include somatostatin analogs and PD-L1 inhibitors.
- Genetically engineered mouse models reveal ONB similarities to small cell lung cancer, informing new strategies.
Conclusions:
- Advanced imaging and genomic profiling enhance diagnostic accuracy for personalized ONB treatments.
- Genetically engineered mouse models and collaborative efforts are crucial for research and molecular testing standardization.
- Integrating advanced imaging, genomic profiling, and targeted therapies promises improved patient outcomes for ONB.
